Fibrinolysis thrombocytopenia coagulation abnormalities high-dose immunotherapy High-dose immunotherapy hypotension respiratory distress interstitial edema thrombocytopenia similar shock direct effect coagulation factors vitro coagulant properties vascular endothelium possibility infusions plasma fibrinolysis intravascular coagulation DIC clinical course platelet count coagulation profile response infusion patients metastatic melanoma metastatic renal cell carcinoma patient hemodynamic instability thrombocytopenia patient unusual complication mesenteric thrombosis patient appreciable changes prothrombin time partial thromboplastin time factors VIII decline patients patients decreased titers Hageman factor factor XII high molecular weight kininogen prekallikrein plasma thromboplastin antecedent reactions intrinsic pathway thrombin formation D-dimer fragments plasma patient point infusion cycle decreased titers plasminogen patients infusions fibrinolysis factor derangements related toxicity phenomena DIC Activation intrinsic contact system coagulation link vascular endothelial surface alterations infusions development systemic toxicity septic shock 